Loading clinical trials...
Loading clinical trials...
The purpose of this study is to test the safety and effectiveness of ribavirin, administered as an aerosol, in preventing progression of upper respiratory tract RSV infection to RSV pneumonia in bone ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NCT07220109 · Respiratory Syncytial Virus Infections
NCT07092865 · Respiratory Syncytial Virus Infections
NCT07239583 · Respiratory Syncytial Virus Infection, Respiratory Syncytial Virus Infections
NCT04732871 · Respiratory Syncytial Virus Infections
NCT06534892 · Respiratory Syncytial Virus Infections
University of Alabama at Birmingham (CASG)
Birmingham, Alabama
City of Hope National Medical Center
Duarte, California
University of California, San Francisco
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions